X. Zhan

发表

HIV-1 vaccine development: tackling virus diversity with a multi-envelope cocktail.

Scott A. Brown, J. Stambas, P. Freiden, 2008, Frontiers in bioscience : a journal and virtual library.

Sendai virus recombinant vaccine expressing a secreted, unconstrained respiratory syncytial virus fusion protein protects against RSV in cotton rats.

K. Boyd, C. Russell, S. Surman, 2015, International immunology.

Structural mapping of antibody landscapes to human betacoronavirus spike proteins

J. Crowe, J. Torres, L. Sewall, 2021, bioRxiv.

Human PIV-2 recombinant Sendai virus (rSeV) elicits durable immunity and combines with two additional rSeVs to protect against hPIV-1, hPIV-2, hPIV-3, and RSV.

C. Russell, V. Mishin, S. Surman, 2009, Vaccine.

Antibody Activity Regions of HIV Envelope Despite Defects in Clustering of Th Cell Epitopes on Exposed

Scott A. Brown, P. Doherty, J. Stambas, 2003 .

Recombinant Sendai Virus Expressing the G Glycoprotein of Respiratory Syncytial Virus (RSV) Elicits Immune Protection against RSV

K. Boyd, S. Krishnamurthy, Y. Nagai, 2004, Journal of Virology.

In Vitro and In Vivo Characterization of a Murine Cytomegalovirus with a Transposon Insertional Mutation at Open Reading Frame M43

Fenyong Liu, X. Zhan, Jianqiao Xiao, 2000, Journal of Virology.

In Vitro and In Vivo Characterization of a Murine Cytomegalovirus with a Transposon Insertional Mutation at Open Reading Frame M 43

Fenyong Liu, X. Zhan, Jianqiao Xiao, 2000 .

Multi-envelope HIV-1 vaccine devoid of SIV components controls disease in macaques challenged with heterologous pathogenic SHIV.

Scott A. Brown, J. Stambas, M. Bonsignori, 2005, Vaccine.

Individual HIV type 1 envelope-specific T cell responses and epitopes do not segregate by virus subtype.

S. Surman, J. Hurwitz, X. Zhan, 2006, AIDS Research and Human Retroviruses.

Evidence of Positive Selection in Spike Glycoprotein

Yulong He, X. Zhan, Leping Yan, 2020 .

Murine Cytomegalovirus Containing a Mutation at Open Reading Frame M37 Is Severely Attenuated in Growth and Virulence In Vivo

Fenyong Liu, T. Tuong, X. Zhan, 2000, Journal of Virology.

Epstein-Barr virus vaccine development: a lytic and latent protein cocktail.

C. Sample, S. Surman, J. Hurwitz, 2008, Frontiers in bioscience : a journal and virtual library.

Murine Cytomegalovirus with a Transposon Insertional Mutation at Open Reading Frame m155 Is Deficient in Growth and Virulence in Mice

G. Abenes, Fenyong Liu, X. Zhan, 2004, Journal of Virology.

Murine Cytomegalovirus with a Transposon Insertional Mutation at Open Reading Frame M35 Is Defective in Growth In Vivo

R. Hai, Sangwei Lu, Fenyong Liu, 2003, Journal of Virology.

In Vitro and In Vivo Characterization of a Murine Cytomegalovirus with a Mutation at Open Reading Frame m166

R. Hai, Sangwei Lu, Fenyong Liu, 2003, Journal of Virology.

In Vitro and In Vivo Characterization of a Murine Cytomegalovirus with a Mutation at Open Reading Frame

R. Hai, Sangwei Lu, Fenyong Liu, 2003 .

Genetic analyses of gene function and pathogenesis of murine cytomegalovirus by transposon-mediated mutagenesis.

G. Abenes, Fenyong Liu, X. Zhan, 2002, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Murine Cytomegalovirus Open Reading Frame M27 Plays an Important Role in Growth and Virulence in Mice

G. Abenes, Fenyong Liu, X. Zhan, 2001, Journal of Virology.

Construction and Characterization of Murine Cytomegaloviruses That Contain Transposon Insertions at Open Reading Frames m09 and M83

Fenyong Liu, X. Zhan, Jianqiao Xiao, 2000, Journal of Virology.

Mutagenesis of murine cytomegalovirus using a Tn3-based transposon.

P. Ross-Macdonald, M. Snyder, G. Abenes, 2000, Virology.

SHIV infection protects against heterologous pathogenic SHIV challenge in macaques: a gold-standard for HIV-1 vaccine development?

J. Hurwitz, X. Zhan, T. Lockey, 2009, Current HIV research.

UV-inactivated vaccinia virus (VV) in a multi-envelope DNA-VV-protein (DVP) HIV-1 vaccine protects macaques from lethal challenge with heterologous SHIV.

P. Freiden, S. Surman, J. Hurwitz, 2012, Vaccine.

HIV vaccines: brief review and discussion of future directions

Scott A. Brown, J. Stambas, M. Bonsignori, 2005, Expert review of vaccines.

Clade, Country and Region-specific HIV-1 Vaccines: Are they necessary?

Scott A. Brown, J. Stambas, P. Freiden, 2005, AIDS research and therapy.

A Multi-Vector, Multi-Envelope HIV-1 Vaccine.

Scott A. Brown, J. Stambas, P. Freiden, 2007, The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG.

Multiple mycobacterial antigens are targets of the adaptive immune response in pulmonary sarcoidosis

W. Drake, C. Jenkins, Susamma Abraham, 2010, Respiratory research.

Clustering of Th Cell Epitopes on Exposed Regions of HIV Envelope Despite Defects in Antibody Activity 1

Scott A. Brown, P. Doherty, J. Stambas, 2003, The Journal of Immunology.

Respiratory syncytial virus (RSV) fusion protein expressed by recombinant Sendai virus elicits B-cell and T-cell responses in cotton rats and confers protection against RSV subtypes A and B.

K. Boyd, S. Krishnamurthy, S. Surman, 2007, Vaccine.

HIV-1 envelope T cell epitope "hotspots " among mice and humans and among CD4+ and CD8+ T cell subpopulations.

Scott A. Brown, J. Hurwitz, X. Zhan, 2007, AIDS research and human retroviruses.

Limited Breadth of a T-Helper Cell Response to a Human Immunodeficiency Virus Envelope Protein

P. Doherty, S. Surman, C. Coleclough, 2003, Journal of Virology.

Recombinant Sendai virus as a novel vaccine candidate for respiratory syncytial virus.

K. Boyd, S. Krishnamurthy, C. Coleclough, 2005, Viral immunology.

Neutralization Fingerprinting Technology for Characterizing Polyclonal Antibody Responses to Dengue Vaccines

I. Georgiev, J. Crowe, Nagarajan Raju, 2021, bioRxiv.

Inhibition of ex vivo-expanded cytotoxic T-lymphocyte function by high-dose cyclosporine

Xiaoyan Zhan, J. Hurwitz, X. Zhan, 2003, Transplantation.

Minor components of a multi-envelope HIV vaccine are recognized by type-specific T-helper cells.

Scott A. Brown, S. Surman, C. Coleclough, 2004, Vaccine.

Sendai virus recombinant vaccine expressing hPIV-3 HN or F elicits protective immunity and combines with a second recombinant to prevent hPIV-1, hPIV-3 and RSV infections.

S. Krishnamurthy, C. Russell, Laura E Luque, 2008, Vaccine.

Clade, Country and Region-specific HIV-1 Vaccines: Are they necessary?

Scott A. Brown, J. Stambas, P. Freiden, 2005, AIDS research and therapy.

Sendai virus recombinant vaccine expressing hPIV-3 HN or F elicits protective immunity and combines with a second recombinant to prevent hPIV-1, hPIV-3 and RSV infections.

S. Krishnamurthy, C. Russell, Laura E Luque, 2008, Vaccine.

Molecular Evolution of SARS-CoV-2 Structural Genes: Evidence of Positive Selection in Spike Glycoprotein

Bihui Huang, Xiao-Yong Zhan, Ke Huang, 2020, bioRxiv.

A Multi-Vector, Multi-Envelope HIV-1 Vaccine

J. Stambas, P. Freiden, M. Bonsignori, 2007 .